Skip to main content

Langzeitbehandlung der Ulcus Duodeni-Erkrankung

  • Conference paper
  • 19 Accesses

Zusammenfassung

Unsere Kenntnisse über den natürlichen Verlauf der Ulcus duodeni- und Ulcus ventriculi-Erkrankung sind nach wie vor begrenzt. Es wurde u.a. angenommen, daß Ulzera zunächst spontan ausheilen können und danach wieder auftreten. Dieser Wechsel zwischen Spontanheilung und Rezidiv soll sich über die gesamte (unbekannte) Dauer der Ulkuserkrankung wiederholen. Seit neuerem weiß man jedoch, daß nur ca. 25% der akuten Duodenal-ulzera innerhalb von bis zu 6 Monaten spontan heilen [1], während die Mehrzahl nicht abheilt und sich z.T. erst durch Schmerzen oder Blutung bemerkbar macht. Auch Ulkusrezidive können erst durch diese Komplikationen klinisch manifest werden. Da Komplikationen (Blutung, Perforation) den Patienten vital bedrohen, ist es in jedem Fall erforderlich, ein Ulkus zur Abheilung zu bringen.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Boyd EJS, Wilson JA, Wormsley KG (1983) Natural history of asymptomatic duodenal ulcers. Gut 24:A470

    Google Scholar 

  2. Wormsley KG (1981) Short-term treatment of duodenal ulceration. In: Baron JH (Hrsg.) Cimetidine in the 80s. Churchill Livingstone, Edinburgh, 3–8

    Google Scholar 

  3. Colin-Jones DG (1981) Gastric ulcer — short-term healing with Cimetidine and other drugs. In: Baron JH (Hrsg.) Cimetidine in the 80s. Churchill Livingstone, Edinburgh, 127–134

    Google Scholar 

  4. Fry J (1964) Peptic ulcer: a profile. Br Med J 2:809–812

    Article  PubMed  CAS  Google Scholar 

  5. Greibe J, Bugge P, Gjørup T, Lauritzen T, Bonnevie O, Wulff HR (1977) Long-term prognosis of duodenal ulcer: Follow-up study and survey of doctors’ estimates. Br Med J 2:1572–1574

    Article  PubMed  CAS  Google Scholar 

  6. Krause U (1963) Long-term results of medical and surgical treatment of peptic ulcer. Acta Chir Scand 125:310

    Google Scholar 

  7. Bardhan KD (1980) Intermittent treatment of duodenal ulcer with Cimetidine. Br Med J 2:20–22

    Article  Google Scholar 

  8. Dawson J, Richards DA, Stables R, Dixon GT, Cockel R (1983) Ranitidine — Pharmacology and clinical use. J Clin Hosp Pharmacy 8:1–13

    CAS  Google Scholar 

  9. Kang JY, Piper DW (1982) Cimetidine and colloidal bismuth in treatment of chronic duodenal ulcer. Digestion 23:73–79

    Article  PubMed  CAS  Google Scholar 

  10. Marks IN, Wright JP, Lucke W, Girdwood AH (1983) Relapse rates following initial ulcer healing with sucralfate and Cimetidine. Scand J Gastroent [Suppl 83] 18:53–56

    Google Scholar 

  11. Cheli R, Giacosa A, Molinari F (1982) Long-term treatment of duodenal ulcer with pirenzepine. Scand J Gastroent [Suppl 72] 17:221–224

    Google Scholar 

  12. Machell RJ (1981) Gastric ulcer — long-term treatment with Cimetidine. In Baron JH (Hrsg.) Cimetidine in the 80s. Churchill Livingstone, Edinburgh, 135–138

    Google Scholar 

  13. Hanscom DH, Buchman E (1971) The Veterans Administration Cooperative study on gastric ulcer: The follow-up period. Gastroenterology 61:585–591

    PubMed  Google Scholar 

  14. Bonnevie O. (1978) Survival in peptic ulcer. Gastroenterology 75:1055–1060

    PubMed  CAS  Google Scholar 

  15. Mignon M, Berrezag R (1981) Le traitement d’entretien de la maladie ulcéreuse duodenale par référence à l’histoire naturelle de la maladie. Chirurgie 107:527–532

    PubMed  CAS  Google Scholar 

  16. Kay PH, Moore KTH, Clark RG (1978) The treatment of perforated duodenal ulcer. Br J Surg 65: 801–803

    Article  PubMed  CAS  Google Scholar 

  17. Muttarini L (1980) A functional view of cost/benefit analysis in peptic ulcer disease. In Torsoli A et al (Hrsg.) Further experience with H2-receptor antagonists in peptic ulcer disease and progress in histamine research Excerpta Medica, Amsterdam, 70–82

    Google Scholar 

  18. Boyd EJS, Wilson JA, Wormsley KG (1983) Safety of ranitidine maintenance treatment of duodenal ulcer. Scand J Gastroent 18

    Google Scholar 

  19. Galeone M, Moise G, Casula PL, Bignamini AA (1981) Eine zweijährige Studie zum Auftreten von Ulkusrezidiven nach Proglumid-Therapie. Med Welt 32:173–175

    PubMed  CAS  Google Scholar 

  20. Miederer SE, Lindstaedt H, Kutz K, Wuttke H (1979) Wirksame ambulante Therapie des Ulcus ventriculi mit Proglumid. Dtsch Med Wochenschr 104:313–315

    Article  PubMed  CAS  Google Scholar 

  21. Martin DF, Hollanders D, May SJ, Ravenscroft MM, Tweedle DEF, Miller JP (1981) Difference in relapse rates of duodenal ulcer after healing with Cimetidine or tripotassium dicitrato bismuthate. Lancet I:7–10

    Article  Google Scholar 

  22. Pounder RE (1981) Model of medical treatment for duodenal ulcer. Lancet I:29–30

    Article  Google Scholar 

  23. Robbs JV, Baker LW (1977) Duodenal perforation — a prospective analysis. S Afr J Surg 15:39–44

    PubMed  CAS  Google Scholar 

  24. Wormsley KG (1979) Duodenal ulcer, vol 2. Eden Press, Montreal and Churchill Livingstone, Edinburgh

    Google Scholar 

  25. Sawyer D, Conner CS, Scalley R (1981) Cimetidine: Adverse reactions and acute toxicity. Am J Hosp Pharm 38:188–197

    PubMed  CAS  Google Scholar 

  26. Koo J, Lam SK (1982) Cimetidine versus surgery for recurrent ulcer after gastric surgery. Ann Surg 195:406–412

    Article  PubMed  CAS  Google Scholar 

  27. Madsen P, Kronborg O (1980) Recurrent ulcer 51/2–8 years after highly selective vagotomy without drainage and selective vagotomy with pyloroplasty. Scand J Gastroent 15:193–199

    Article  PubMed  CAS  Google Scholar 

  28. Rösch W (1977) Moderne Ulkuschirurgie aus der Sicht des Internisten. Fortschr Med 95:1851–1854

    PubMed  Google Scholar 

  29. Ellis DJ, Kingston RD, Brookes VS, Waterhouse JAH (1979) Gastric carcinoma and previous peptic ulceration. Br J Surg 66:117–119

    Article  PubMed  CAS  Google Scholar 

  30. Dahm K, Werner B (1976) Susceptibility of the resected stomach to experimental carcinogenesis. Z Krebsforsch 85:219–229

    Article  CAS  Google Scholar 

  31. Fujita M, Takami M, Usugane M, Nampei S, Taguchi T (1979) Enhancement of gastric carcinogenesis in dogs given N-methyl-N’-nitro-N-nitroso-guanidine following vagotomy. Cancer Res 39:811–816

    PubMed  CAS  Google Scholar 

  32. Elder JB, Ganguli PC, Gillespie IE (1979) Cimetidine and gastric cancer. Lancet I:1005–1006

    Article  Google Scholar 

  33. Stockbrugger RW, Cotton PB, Eugenides N, Bartholemew BA, Hill MJ, Walters GL (1982) Intragastric nitrites, nitrosamines and bacterial overgrowth during Cimetidine treatment. Gut 23:1048–1054

    Article  PubMed  CAS  Google Scholar 

  34. Musgrove TJ, Youngs DJ, Burdon DW, Keighley MRB (1981) Cimetidine is unlikely to increase formation of intragastric N-nitroso-compounds in patients taking a normal diet. Lancet I:408–409

    Google Scholar 

  35. Editorial (1981) Does Cimetidine cause gastric cancer? Br Med J 282:1178–1179

    Article  Google Scholar 

  36. Small WP (1980) The results of surgery for duodenal ulcer. Scot Med J 25:281–286

    PubMed  CAS  Google Scholar 

  37. Sonnenberg A, Hefti ML (1979) The cost of postsurgical syndromes (based on the example of duodenal ulcer treatment). Clin Gastroent 8:235–248

    CAS  Google Scholar 

  38. Culyer AJ, Maynard AK (1981) Cost-effectiveness of duodenal ulcer treatment. Soc Sci Med 150:3–11

    Google Scholar 

  39. Cargill JM, Peden NR, Saunders JHB, Wormsley KG (1978) Very long-term treatment of peptic ulcer with Cimetidine. Lancet II:1113–1115

    Article  Google Scholar 

  40. Boyd EJS, Wilson JA, Wormsley KG (1983) Review of ulcer treatment: Role of ranitidine. Zur Publikation eingereicht

    Google Scholar 

  41. Boyd EJS, Wilson JA, Wormsley KG (1983) Effects of treatment compliance and overnight gastric secretion on outcome of maintenance therapy of duodenal ulcer with ranitidine. Scand J Gastroent 18:193–200

    Article  PubMed  CAS  Google Scholar 

  42. Henry DA, Langman MJS (1981) Adverse effects of anti-ulcer drugs. Drugs 21:444–459

    Article  PubMed  CAS  Google Scholar 

  43. Taylor RH, Menzies-Gow N, Lovell D, La Brooy SJ, Misiewicz JJ (1978) Misleading response of malignant gastric ulcers to Cimetidine. Lancet I:686–688

    Article  Google Scholar 

  44. Editorial (1981) Gastric ulcer: Benign or malign? Br Med J 282:843

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Wormsley, K.G. (1984). Langzeitbehandlung der Ulcus Duodeni-Erkrankung. In: Wormsley, K.G., Dammann, HG., Simon, B. (eds) H2-Blocker in der Therapie säurebedingter Erkrankungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70040-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70040-8_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-13800-6

  • Online ISBN: 978-3-642-70040-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics